SLC1A5 and small cell lung carcinoma: ASC amino acid transporter 2 (ASCT2) promotes the malignant phenotype of small-cell lung cancer by enhancing cellular uptake of glutamine, leading to enhanced cell proliferation and migration through phosphorylation of the mTOR1 pathway (31).